PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus

7 months ago

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…

IOC Executive Board approves Olympic medal reallocations for Vancouver 2010 and Sochi 2014

7 months ago

19 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) today took the decision to reallocate Olympic medals, diplomas and medallist…

IOC Executive Board approves 13 athletes changes of sporting nationality for the Milano Cortina 2026 Olympic Winter Games

7 months ago

19 September 2025 - Today, during the second day of its meeting in Milan, the International Olympic Committee (IOC) Executive Board (EB)…

IOC reaffirms: Sport must unite the world in peaceful competition

7 months ago

19 September 2025 - In a world shaken by conflict and division, the International Olympic Committee (IOC) Executive Board (EB) stands firm in…

Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!

7 months ago

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction – What is Bravo Flowdex Bravo Flowdex is a…

Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!

7 months ago

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Net Rowdex Net Rowdex emerges in 2025 as…

Immediate Edge: Exploring the AI Technology Behind Immediate Edge Trading Platform Germany Insights!

7 months ago

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Immediate Edge Immediate Edge is a cutting-edge AI-powered…

Sasken Partners with VicOne to Deliver End-to-End Automotive Cybersecurity Solutions

7 months ago

BENGALURU, India, Sept. 20, 2025 /PRNewswire/ -- Sasken Technologies Limited, a leader in product engineering and digital transformation, today announced…

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

7 months ago

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting

7 months ago

NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…